SRC and breast carcinoma: Breast cancer cells treated with T3 triggered a significant increase of phospho-paxillinTyr118 at the cell membrane periphery where cortical actin complexes were formed, and this was impaired by the blockade of Src (PP2), FAK (FAKi), and paxillin (siRNAs) (Figures 3E,F).